TM
DGX icon

Torren Management’s Quest Diagnostics DGX Stock Holding History

Torren Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59K Hold
12
– – ﹤0.01% 500
2026
Q1 		$2.39K Sell
12
-398
-97% -$77.3K ﹤0.01% 507
2025
Q4 		$71.2K Buy
+410
New +$74.7K 0.04% 230

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Torren Management's DGX Position: Q2 2026 in Review

Torren Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 12 shares worth $2.59K. The position accounts for ﹤0.01% of the portfolio, ranked #500.

Torren Management first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. The position peaked at $71.2K in Q4 2025. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Torren Management held 12 shares of Quest Diagnostics worth $2.59K as of Q2 2026.
  • Torren Management left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #500 holding.
  • Torren Management first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's Quest Diagnostics position peaked at $71.2K in Q4 2025.
  • 629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.